China Biologic Products Stock News

China Biologic Products Holdings Inc (NASDAQ:CBPO)’s share price shot up 0.9% during trading on Tuesday . The company traded as high as $105.76 and last traded at $106.11, 3,756 shares were traded d

Pharmacyte Biotech (OTCMKTS:PMCB) and China Biologic Products (NASDAQ:CBPO) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of th

Cubist Systematic Strategies LLC grew its holdings in China Biologic Products Holdings Inc (NASDAQ:CBPO) by 333.0% in the fourth quarter, according to the company in its most recent Form 13F filing wi

Marshall Wace LLP lowered its holdings in shares of China Biologic Products Holdings Inc (NASDAQ:CBPO) by 99.4% during the 4th quarter, according to the company in its most recent filing with the SEC.

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Im

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa

Goldman Sachs Group Inc. boosted its stake in China Biologic Products Holdings Inc (NASDAQ:CBPO) by 154.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securi

China Biologic Products (NASDAQ:CBPO) was upgraded by stock analysts at ValuEngine from a “sell” rating to a “hold” rating in a research note issued to investors on Thursday, ValuEngine report

Credit Suisse AG lifted its position in China Biologic Products Holdings Inc (NASDAQ:CBPO) by 6.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Excha

China Biologic Products (NASDAQ:CBPO) and BioNTech (NASDAQ:BNTX) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their insti